Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1783, doi. 10.1038/sj.gt.3301268
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2000 AND VI 7 AND IP 20
Results: 12
1
2
The treatment of established intracranial tumors by in situ retroviral IFN-γ transfer.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1715, doi. 10.1038/sj.gt.3301273
- By:
- Publication type:
- Article
3
Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1753, doi. 10.1038/sj.gt.3301282
- By:
- Publication type:
- Article
4
In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1738, doi. 10.1038/sj.gt.3301286
- By:
- Publication type:
- Article
5
In vivo correction of genetic defects of monocyte/ macrophages using attenuated Salmonella as oral vectors for targeted gene delivery.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1725, doi. 10.1038/sj.gt.3301290
- By:
- Publication type:
- Article
6
Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1731, doi. 10.1038/sj.gt.3301295
- By:
- Publication type:
- Article
7
Regulated hepatic insulin gene therapy of STZ-diabetic rats.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1744
- By:
- Publication type:
- Article
8
Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1761, doi. 10.1038/sj.gt.3301299
- By:
- Publication type:
- Article
9
Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann–Pick disease.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1768, doi. 10.1038/sj.gt.3301300
- By:
- Publication type:
- Article
10
Production of first generation adenovirus vectors: a review.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1707, doi. 10.1038/sj.gt.3301301
- By:
- Publication type:
- Article
11
Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1777, doi. 10.1038/sj.gt.3301303
- By:
- Publication type:
- Article
12
The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells.
- Published in:
- Gene Therapy, 2000, v. 7, n. 20, p. 1790, doi. 10.1038/sj.gt.3301304
- By:
- Publication type:
- Article